Atai Life Sciences Increases IPO To $225 Million
Atai Life Sciences (NASDAQ: ATAI) late last night announced the pricing of its upsized initial public offering. The clinical-stage biotech
Read more
Atai Life Sciences
Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health
In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably been that of the growing
Read more